Seagen
SGEN
#581
Rank
NZ$76.61 B
Marketcap
NZ$406.11
Share price
-0.07%
Change (1 day)
72.88%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -NZ$1.29 Billion

According to Seagen 's latest financial reports the company's current earnings are NZ$2.30 Billion. In 2022 the company made an earning of -NZ$1.09 Billion, an increase over its 2021 earnings that were of -NZ$1.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$1.29 Billion17.89%
2022 -NZ$1.09 Billion-10.13%
2021 -NZ$1.22 Billion-214.28%
2020 NZ$1.05 B-370.63%
2019 -NZ$0.4 Billion-15.17%
2018 -NZ$0.47 Billion32.79%
2017 -NZ$0.35 Billion37.19%
2016 -NZ$0.26 Billion18%
2015 -NZ$0.22 Billion56.34%
2014 -NZ$0.14 Billion23.07%
2013 -NZ$0.12 Billion
2011 -NZ$0.26 Billion111.72%
2010 -NZ$0.13 Billion-19.63%
2009 -NZ$0.16 Billion-7.55%
2008 -NZ$0.17 Billion64.95%
2007 -NZ$98.8 Million38.4%
2006 -NZ$71.38 Million25.36%
2005 -NZ$56.94 Million-14.86%
2004 -NZ$66.88 Million61.92%
2003 -NZ$41.31 Million-7.67%
2002 -NZ$44.74 Million6.76%
2001 -NZ$41.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.26 B-973.67%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$15.44 B-1,200.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$1.79 B-227.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.14 B-1,606.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$14.00 B-1,097.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-NZ$0.12 Billion-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.58 Billion-58.79%๐Ÿ‡บ๐Ÿ‡ธ USA